TNNI3 and COVID-19: A recent study suggests that myocardial injury, indicated by elevated hs-cTnI (>99th percentile) during COVID-19 hospitalization is linked to increased post-discharge mortality and major adverse cardiovascular and cerebrovascular events, underscoring its prognostic importance in COVID-19 survivors [301].